235 related articles for article (PubMed ID: 16621041)
1. In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections.
Quenelle DC; Keith KA; Kern ER
Antiviral Res; 2006 Aug; 71(1):24-30. PubMed ID: 16621041
[TBL] [Abstract][Full Text] [Related]
2. The effect of certain mannich N-bases, derivatives of isatin beta-thiosemicarbazone, on the replication of vaccinia virus in in vitro studies.
Borysiewicz J; Lucka-Sobstel B
Acta Microbiol Pol; 1978; 27(2):111-21. PubMed ID: 80923
[TBL] [Abstract][Full Text] [Related]
3. The antiviral activity of isatin beta-thiosemicarbazone derivatives on vaccinia virus infection in mice.
Zgórniak-Nowosielska I; Gatkiewicz A; Poteć Z
Arch Immunol Ther Exp (Warsz); 1976; 24(4):597-601. PubMed ID: 999472
[TBL] [Abstract][Full Text] [Related]
4. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
Quenelle DC; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of vaccinia virus replication in RK-13 cells by N,N'-bis(methylisatin-beta-thiosemicarbazone)-2-methylpiperazine.
Bańkowski A; Filczak K; Korbecki M
Acta Virol; 1986 May; 30(3):192-8. PubMed ID: 2874722
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice.
Quenelle DC; Buller RM; Parker S; Keith KA; Hruby DE; Jordan R; Kern ER
Antimicrob Agents Chemother; 2007 Feb; 51(2):689-95. PubMed ID: 17116683
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice.
Quenelle DC; Collins DJ; Herrod BP; Keith KA; Trahan J; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2007 Nov; 51(11):3940-7. PubMed ID: 17846137
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of vaccinia, sindbis and para-influenza virus replication by isatin beta-thiosemicarbazone derivative and methisazone in vitro and in vivo].
Poteć Z; Zgórniak-Nowosielska I
Folia Med Cracov; 1979; 21(1):3-13. PubMed ID: 232050
[No Abstract] [Full Text] [Related]
9. Inhibition of poxvirus growth by Terameprocol, a methylated derivative of nordihydroguaiaretic acid.
Pollara JJ; Laster SM; Petty IT
Antiviral Res; 2010 Dec; 88(3):287-95. PubMed ID: 20888364
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
Quenelle DC; Collins DJ; Kern ER
Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041
[TBL] [Abstract][Full Text] [Related]
11. Site of action of N,N'-bis(methylisatin-beta-thiosemicarbazone)-2-methylpiperazine in the vaccinia virus replication cycle.
Rada B; Zgórniak-Nowosielska I
Acta Virol; 1984 Sep; 28(5):428-32. PubMed ID: 6151358
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of orthopoxvirus replication by a small interfering RNA targeting the D5R gene.
Vigne S; Germi R; Duraffour S; Larrat S; Andrei G; Snoeck R; Garin D; Crance JM
Antivir Ther; 2008; 13(3):357-68. PubMed ID: 18572748
[TBL] [Abstract][Full Text] [Related]
13. The effect of inhibitors on the growth of the entomopoxvirus from Amsacta moorei in Lymantria dispar (gypsy moth) cells.
Winter J; Hall RL; Moyer RW
Virology; 1995 Aug; 211(2):462-73. PubMed ID: 7645250
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial optimization of isatin-beta-thiosemicarbazones as anti-poxvirus agents.
Pirrung MC; Pansare SV; Sarma KD; Keith KA; Kern ER
J Med Chem; 2005 Apr; 48(8):3045-50. PubMed ID: 15828843
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of ectodermal lesions in intravenous vaccinia infected mice as a method to investigate the antiviral activity of isatin beta-thiosemicarbazone derivative (TSK VI compound).
Walter M; Kolarz B; Zgórniak-Nowosielska I
Arch Immunol Ther Exp (Warsz); 1981; 29(2):187-94. PubMed ID: 7305631
[TBL] [Abstract][Full Text] [Related]
16. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
[TBL] [Abstract][Full Text] [Related]
17. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge.
Yang G; Pevear DC; Davies MH; Collett MS; Bailey T; Rippen S; Barone L; Burns C; Rhodes G; Tohan S; Huggins JW; Baker RO; Buller RL; Touchette E; Waller K; Schriewer J; Neyts J; DeClercq E; Jones K; Hruby D; Jordan R
J Virol; 2005 Oct; 79(20):13139-49. PubMed ID: 16189015
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.
Sauerbrei A; Meier C; Meerbach A; Schiel M; Helbig B; Wutzler P
Antiviral Res; 2005 Sep; 67(3):147-54. PubMed ID: 16076502
[TBL] [Abstract][Full Text] [Related]
19. The effect of isatin beta thiosemicarbazone (IBT)-related compounds on IBT-resistant and on IBT-dependent mutants of vaccinia virus.
Katz E; Margalith E; Winer B
J Gen Virol; 1974 Nov; 25(2):239-44. PubMed ID: 4373528
[No Abstract] [Full Text] [Related]
20. Activity of some isatin-beta-thiosemicarbazone and hydrazine dimethylxanthine derivatives against vaccinia virus in chick cells by agar diffusion method.
Porebska A; Potec Z; Borysiewicz J
Acta Microbiol Pol A; 1973; 5(3):208-11. PubMed ID: 4797706
[No Abstract] [Full Text] [Related]
[Next] [New Search]
